Pfizer’s ABRYSVO Shows Promise as RSV Vaccine for At-Risk Adults: Phase 3 Study ResultsBy bigbreakingwire on April 9, 2024
Pfizer’s Plan to Sold Roughly 630 Million Haleon Shares in Consumer Healthcare Shift Pfizer’s Plan to Sold Roughly 630 Million Haleon Shares in Consumer Healthcare ShiftBy bigbreakingwire on March 18, 2024
